TL;DR
- The News: Cent, founded by Shashank ND (Practo) and former executives from Ola Electric and Lenskart, has raised an undisclosed seed round (estimated at $5M) from OneFlow and South Park Commons.
- The Focus: AI-driven early detection of cancer, cardiac, neurological, and metabolic diseases.
- The Goal: Moving India's healthcare from "reactive treatment" to "proactive screening."
Vichaarak Perspective
For over a decade, the Indian healthtech story was about discovery—finding a doctor or booking a lab test. While Practo solved the "where," Cent is attempting to solve the "when." By integrating AI into the screening layer, they are tackling the most expensive problem in healthcare: late diagnosis.
The pedigree of the founding team suggests a "Blitzscaling of Science" approach. This is the first major signal in 2026 that the ecosystem is ready to move beyond SaaS-style marketplaces into deep-tech clinical intervention. The real "Alpha" here isn't the app; it's the data moat they build by catching diseases before they become symptoms.
FAQ
What makes Cent different from existing diagnostic apps? Most current apps are aggregators of existing labs. Cent is building an autonomous AI layer that analyzes screening data to predict disease risks before traditional symptoms appear.
Who are the investors? The round was led by OneFlow Holdings (Shashank ND’s family office) and South Park Commons, a Silicon Valley-based venture builder known for backing high-conviction technical founders.
Why is this important for the Indian middle class? Early detection reduces long-term medical costs by up to 80% for chronic diseases, making this a critical tool for financial and physical longevity in the "Villa Fund" era.